Unicycive Therapeutics (UNCY)
(Delayed Data from NSDQ)
$3.96 USD
-0.13 (-3.18%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $3.98 +0.02 (0.51%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Unicycive Therapeutics, Inc. has a market cap of $72.24M, which represents its share price of $4.09 multiplied by its outstanding shares number of 17.66M. As a small-cap company, UNCY's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
UNCY 3.96 -0.13(-3.18%)
Will UNCY be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for UNCY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for UNCY
DaVita Stock Declines 1.2% in 3 Months: Here's How to Play
UNCY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for UNCY
UNCY forms Bollinger Band Squeeze on September 20
Is UNCY consolidating before a move? Bollinger Band Squeeze shows up after climbing 1.24%
NR7 appears for UNCY after 1.25% move
UNCY forms 20 Day Moving Average Resistance on September 16
Is UNCY likely to continue lower? Stochastic Reached Oversold shows up after gaining 1.81%